Observational × Carcinoma, Non-Small-Cell Lung × Clear all Metabolomic Characteristics of Patients With Non-small Cell Lung Cancer in Plasma, Tissue and Exhaled Breath Condensate: A Case-control Study
Completed
74 enrolled
Harvesting Cells for Experimental Cancer Treatments
Enrolling by invitation
7,000 enrolled
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Recruiting
2,000 enrolled
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Recruiting
500 enrolled
Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI
Completed
296 enrolled
Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland
Completed
240 enrolled
Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment
Recruiting
90 enrolled
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
Active not recruiting
1,336 enrolled
National Cancer Institute "Cancer Moonshot Biobank"
Active not recruiting
1,600 enrolled
Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer
Completed
182 enrolled
TraveraRTGx
Completed
72 enrolled
ENTIRETY
Active not recruiting
50 enrolled
A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery
Active not recruiting
1,200 enrolled
RAISE
Phase 2 Recruiting
60 enrolled
LEPIDOPTERA
Recruiting
380 enrolled
The Research Plan of Taiwan Precision Medicine
Recruiting
550 enrolled
SORT
Active not recruiting
446 enrolled
Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients
Completed
102 enrolled
Real-world Association Between Concomitant Beta-blocker Exposure and Anti-PD-1/PD-L1 Treatment Outcomes in Advanced Non-Small Cell Lung Cancer
Completed
60 enrolled
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Recruiting
800 enrolled
FL-261 Imaging for Cancer Diagnosis and Staging
Recruiting
12 enrolled
IKF-ReWoLuTe
Recruiting
240 enrolled
MK-3475-U01
Recruiting
1,065 enrolled
Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD
Recruiting
45 enrolled
Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
Recruiting
80 enrolled
FAP-targeted PET/NIR in Lung Malignant Tumors
Recruiting
200 enrolled
Safety and Efficacy of Xalkori ROS1
Active not recruiting
97 enrolled
Immune and Genomic Markers in ALK+ NSCLC
Active not recruiting
100 enrolled
NAUTIC
Recruiting
600 enrolled
Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery
Recruiting
142 enrolled
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Recruiting
538 enrolled
A Retrospective Real-World Study Based on RATIONALE-307
Recruiting
109 enrolled
Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases
Active not recruiting
300 enrolled
CHOICE
Recruiting
590 enrolled
PET-CT Predicting Lymph Nodes Metastasis
Active not recruiting
280 enrolled
UmbREALung
Recruiting
300 enrolled
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Recruiting
300 enrolled
Emulation of the KEYNOTE-042 (NCT02220894) Trial Using Specialty Oncology Electronic Health Records Databases
Active not recruiting
770 enrolled
Magnetic Resonance Imaging of the Lung: Oncological Applications
Recruiting
50 enrolled
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
Completed
24 enrolled
LBM-T790M
Completed
70 enrolled
Clinical Outcomes and Quality Of Life After Minimally Invasive Segmentectomy Versus Lobectomy for Lung Cancer
Recruiting
180 enrolled
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Suspended
22 enrolled
CEMI-LUNG
Recruiting
500 enrolled
Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes
Recruiting
300 enrolled
Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer
Recruiting
500 enrolled
NIS durvalumab
Active not recruiting
250 enrolled
COSMIC
Recruiting
2,000 enrolled
ORI-EGI-03
Recruiting
450 enrolled
Experiences w/ & Attitudes Towards Immune Chckpt Inhibitors in NSCLC Patients Single Center Survey Based Study
Recruiting
40 enrolled